Literature DB >> 12556666

Introduction: management of hypertension and cardiovascular risk factors in African Americans.

Keith C Ferdinand1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12556666      PMCID： PMC8099259          DOI： 10.1111/j.1524-6175.2003.02016.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  7 in total

1.  Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Richard H. Grimm; Karen L. Margolis; William C. Cushman; Charles E. Ford; Judy Bettencourt; Michael H. Alderman; Jan N. Basile; Henry R. Black; John Eckfeldt; C. Morton Hawkins; H. Mitchell Perry; Michael Proschan
Journal:  Hypertension       Date:  2001-01       Impact factor: 10.190

2.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

3.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

4.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

5.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

6.  Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  J Community Health       Date:  1984

7.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.

Authors:  L J Appel; T J Moore; E Obarzanek; W M Vollmer; L P Svetkey; F M Sacks; G A Bray; T M Vogt; J A Cutler; M M Windhauser; P H Lin; N Karanja
Journal:  N Engl J Med       Date:  1997-04-17       Impact factor: 91.245
  7 in total
  1 in total

1.  Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study.

Authors:  Praveen Veerabhadrappa; Keith M Diaz; Deborah L Feairheller; Kathleen M Sturgeon; Sheara Williamson; Deborah L Crabbe; Abul Kashem; Debra Ahrensfield; Michael D Brown
Journal:  J Am Soc Hypertens       Date:  2010 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.